Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

Summary

The purpose of this study is to determine if SKI-606 (Bosutinib) is effective in the treatment of advanced or metastatic breast cancer. Patients must have current Stage IIIB, IIIC or IV breast cancer and have progressed after 1 to 3 prior chemotherapy regimens.

Timeline

Start

2006-05

Primary completion

2009-02

Completion

2009-02

Drugs

Indications